The Chemours Company offers high performance chemicals in North America, Asia Pacific, Europe, the Middle East, Africa and Latin America. The company is headquartered in Wilmington, Delaware.
| Revenue (TTM) | $5.82B |
| Gross Profit (TTM) | $885.00M |
| EBITDA | $581.00M |
| Operating Margin | 2.97% |
| Return on Equity | -103.00% |
| Return on Assets | 2.13% |
| Revenue/Share (TTM) | $38.69 |
| Book Value | $1.43 |
| Price-to-Book | 14.95 |
| Price-to-Sales (TTM) | 0.55 |
| EV/Revenue | 1.21 |
| EV/EBITDA | 23.16 |
| Quarterly Earnings Growth (YoY) | -64.60% |
| Quarterly Revenue Growth (YoY) | 1.00% |
| Shares Outstanding | $150.38M |
| Float | $149.95M |
| % Insiders | 0.36% |
| % Institutions | 88.59% |
Volatility is currently contracting